18 May 2013
Keywords: eli, lilly/amylin, exenatide, shows, promise, type, diabetes
Article | 13 September 2004
At a press briefing at the annual meeting of the European Associationfor the Study of Diabetes, held in Munich, Germany, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 September 2004
17 May 2013
© 2013 thepharmaletter.com